Skip to Main Content

Author Details

Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1994
249
73
PMIDPaper TitleJournal TitlePublished Year
35988688Interventional radiology meets immuno-oncology for hepatocellular carcinoma.J Hepatol2024
38049623Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping.Nat Med2024
37770128Immunosuppressive CD29<sup>+</sup> Treg accumulation in the liver in mice on checkpoint inhibitor therapy.Gut2024
36627186'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCC.Gut2023
37865722Liquid biopsy epigenomic profiling for cancer subtyping.Nat Med2023
37595566Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.Cell2023
37624046CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18.J Immunol2023
37980571Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing.Cell Rep2023
37726418Biomarkers for immunotherapy of hepatocellular carcinoma.Nat Rev Clin Oncol2023
37533601Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States.J Hepatocell Carcinoma2023
36957974The Microbiome and Liver Cancer.Cancer J2023
37081117Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity.Nat Rev Cancer2023
37428789The current landscape of therapies for hepatocellular carcinoma.Carcinogenesis2023
37295398Medication effects on the gut microbiome in allo-HCT.Cell2023
37094826Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.Hepatology2023
37224815Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.Cell Rep Med2023
36697706Immunology and immunotherapy of cholangiocarcinoma.Nat Rev Gastroenterol Hepatol2023
36692965Top advances of the year: Hepatobiliary cancers.Cancer2023
36932227Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.Nat Rev Gastroenterol Hepatol2023
36754451Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer.J Immunother Cancer2023
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
35474866MPA<sub>PASS</sub> software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays.Cell Rep Methods2022
35378172Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.J Hepatol2022
35833139Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma.Front Immunol2022
35366023Innate lymphoid cells at the crossroads of innate and adaptive immunity.Hepatology2022
36476645Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer.Nat Commun2022
36175037Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).J Immunother Cancer2022
36055226Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD.Cancer Cell2022
35274717A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.Oncologist2022
35331674The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.Trends Cancer2022
35198900NAFLD indirectly impairs antigen-specific CD8<sup>+</sup> T cell immunity against liver cancer in mice.iScience2022
32430997Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.Hepatology2021
33510460Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2021
33674593Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma.Nat Commun2021
33508529MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target.Cell Immunol2021
33811727A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.Clin Transl Sci2021
34518290Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.J Immunother Cancer2021
34104639Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma.J Hepatocell Carcinoma2021
34216724Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.J Hepatol2021
34013212Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production <i>in vivo</i> and <i>in vitro</i>.STAR Protoc2021
34033968Anti-PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice.Cell Mol Gastroenterol Hepatol2021
34260842Hepatocellular Carcinoma - Origins and Outcomes.N Engl J Med2021
34193462Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.Cancer Immunol Res2021
33276030CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.J Hepatol2021
33397682Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2021
33271159Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.J Hepatol2021
33323397Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma.Cancer Discov2021
33235387Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.Cell Mol Immunol2021
33010248Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice.Gastroenterology2021
31520528Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.Hepatology2020
  • 1 - 50 of 249

Recommended Authors

Khashayar Asadi
Austin Hospital
Career Start Year 2015
Number of shared co-authors 0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 3
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Lili Yang
University of California Los Angeles
Career Start Year 2009
Number of shared co-authors 0
Shu Zhang
The Second Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 2007
Number of shared co-authors 1
Ligong Lu
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year 2007
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Celina Ang
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 1
Masahiko Tameda
Mie University Graduate School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
Ana Lleo
Humanitas University
Career Start Year 2003
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Ivy X Chen
Massachusetts General Hospital
Career Start Year 2002
Number of shared co-authors 1
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 6
Frank Tacke
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 8
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 1
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 1
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 1
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 3
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 2
Martin D McCarter
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 4

Collaborators

Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 66
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 30
Bernd Heinrich
Clinic for Gastroenterology, Hannover Medical School
Co-authored papers 25
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Co-authored papers 21
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers 15
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 15
Qianfei Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 14
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 9
Qiong Fu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
Mathuros Ruchirawat
Chulabhorn Research Institute
Co-authored papers 7
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
David Agdashian
university of california san diego, 9452 Medical Center Drive
Co-authored papers 5
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Eytan Ruppin
National Cancer Institute
Co-authored papers 5
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
Milan Sandhu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Alexander Kroemer
Co-authored papers 4
Miaojun Han
Department of Research and Development, Shanghai United Imaging Intelligence Co.
Co-authored papers 4
Lars Zender
Co-authored papers 3
Hien Dang
Co-authored papers 3
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Co-authored papers 3
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 3
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Masaki Terabe
National Cancer Institute
Co-authored papers 3
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 2
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 2
Patrick Y Wen
Co-authored papers 2
Michael Ott
Co-authored papers 2
Release 1.2